Search

everythinglearnresearchcommunity

for

Search:↓

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.

Changes in genes FGA, VWF, and ACTG1 may contribute to pemphigus vulgaris.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

New gene variants were found for rare skin and hair disorders, improving understanding and treatment.

PCOS involves genetic and immune factors, especially T cells, affecting its development.

Acne may signal underlying metabolic issues, and lifestyle changes can help manage both.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

IGF2BP3 and other m6A-related genes are linked to keloid formation and could be potential treatment targets.

CD4 T cells can cause alopecia areata by activating CD8 T cells to attack hair follicles.

Male and female pattern hair loss have different molecular pathways, suggesting unique treatment targets for each sex.

IL-17 and certain immune cells are linked to more severe alopecia areata.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Isotretinoin effectively treats severe acne but can affect blood and inflammation markers, posing risks for some people.

Microbial biofilms may cause red scrotum syndrome.

High-throughput LC-MS screening is effective for finding new autotaxin inhibitors for asthma treatment.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Keratin gene mutations cause various skin and hair disorders, but new research offers hope for future treatments.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

CTE and FPHL are different hair loss types with unique causes.

Chemotherapy-induced hair loss may be linked to immune system changes, and certain treatments could help but need careful use.

Isotretinoin can safely and effectively control acne with proper risk management and monitoring.

Etanercept may not prevent alopecia areata from coming back.

Keloid scars may form due to changes in skin cell characteristics and specific protein signaling.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

Microtrauma techniques like microneedling and PRP can help regrow hair in non-scarring alopecia.

Targeted immune modulation can help achieve stable remission in alopecia areata.

Psoriasis and gout are linked, with each increasing the risk of the other.

Alopecia areata may involve stress-related changes affecting hormone receptors, leading to reduced cortisol production.

Hereditary factors affect acne duration, not severity, and late-onset acne in females has different causes.